|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Li Z, Shan F, Miao R, Xue K, Li Z,
Gao C, Chen N, Gao X, Li S and Ji J: Current status of diagnosis
and treatment of early gastric cancer in China-Data from China
gastrointestinal cancer surgery union. Zhonghua Wei Chang Wai Ke Za
Zhi. 21:168–174. 2018.(In Chinese). PubMed/NCBI
|
|
3
|
Wang FH, Shen L, Li J, Zhou ZW, Liang H,
Zhang XT, Tang L, Xin Y, Jin J, Zhang YJ, et al: The Chinese
Society of Clinical Oncology (CSCO): Clinical Guidelines for the
Diagnosis and Treatment of Gastric Cancer. Cancer Commun (Lond).
39:102019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen K, Yang D, Li X, Sun B, Song F, Cao
W, Brat DJ, Gao Z, Li H, Liang H, et al: Mutational landscape of
gastric adenocarcinoma in Chinese: Implications for prognosis and
therapy. Proc Natl Acad Sci USA. 112:1107–1112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fujisawa H, Takagi S and Hirata T:
Growth-associated expression of a membrane protein, neuropilin, in
Xenopus optic nerve fibers. Dev Neurosci. 17:343–349. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Muhl L, Folestad EB, Gladh H, Wang Y,
Moessinger C, Jakobsson L and Eriksson U: Neuropilin 1 binds PDGF-D
and is a co-receptor in PDGF-D-PDGFRβ signaling. J Cell Sci.
130:1365–1378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Raimondi C: Neuropilin-1 enforces
extracellular matrix signalling via ABL1 to promote angiogenesis.
Biochem Soc Trans. 42:1429–1434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karaman S, Leppänen VM and Alitalo K:
Vascular endothelial growth factor signaling in development and
disease. Development. 145(pii): dev1510192018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shibuya M and Claesson-Welsh L: Signal
transduction by VEGF receptors in regulation of angiogenesis and
lymphangiogenesis. Exp Cell Res. 312:549–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farooqi AA and Siddik ZH: Platelet-derived
growth factor (PDGF) signalling in cancer: Rapidly emerging
signalling landscape. Cell Biochem Funct. 33:257–265. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heldin CH, Lennartsson J and Westermark B:
Involvement of platelet-derived growth factor ligands and receptors
in tumorigenesis. J Intern Med. 283:16–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sa-Nguanraksa D, Kooptiwut S,
Chuangsuwanich T, Pongpruttipan T, Malasit P and O-Charoenrat P:
Vascular endothelial growth factor polymorphisms affect gene
expression and tumor aggressiveness in patients with breast cancer.
Mol Med Rep. 9:1044–1048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glubb DM, Cerri E, Giese A, Zhang W, Mirza
O, Thompson EE, Chen P, Das S, Jassem J, Rzyman W, et al: Novel
functional germline variants in the VEGF receptor 2 gene and their
effect on gene expression and microvessel density in lung cancer.
Clin Cancer Res. 17:5257–5267. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oken M, Creech R, Tormey D, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A III: AJCC Cancer Staging Manual. 7th.
Springer; New York, NY: 2010
|
|
18
|
National Cancer Institute (NCI), . Common
Terminology Criteria for Adverse Events CTCAE). Version 4.03.
2010.
|
|
19
|
Berardi R, Torniai M, Partelli S, Rubini
C, Pagliaretta S, Savini A, Polenta V, Santoni M, Giampieri R,
Onorati S, et al: Impact of vascular endothelial growth factor
(VEGF) and vascular endothelial growth factor receptor (VEGFR)
single nucleotide polymorphisms on outcome in
gastroenteropancreatic neuroendocrine neoplasms. PLoS One.
13:e01970352018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu X, Wang Y, Xue W, Wang R, Wang L, Zhu
ML and Zheng L: The VEGFR-2 protein and the VEGFR-2 rs1870377
A>T genetic polymorphism are prognostic factors for gastric
cancer. Cancer Biol Ther. 20:497–504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang W, Ma XP, Shi Z, Zhang P, Ding DL,
Huang HX, Saiyin HG, Chen TY, Lu PX, Wang NJ, et al: Epidermal
growth factor receptor pathway polymorphisms and the prognosis of
hepatocellular carcinoma. Am J Cancer Res. 5:396–410.
2015.PubMed/NCBI
|
|
22
|
Kim MK, Suh C, Chi HS, Cho HS, Bae YK, Lee
KH, Lee GW, Kim IS, Eom HS, Kong SY, et al: VEGFA and VEGFR2
genetic polymorphisms and survival in patients with diffuse large B
cell lymphoma. Cancer Sci. 103:497–503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim MJ, Kim SK, Park HJ, Chung DH, Park
HK, Lee JS, Kwon KH and Chung JH: PDGFRA promoter polymorphisms are
associated with the risk of papillary thyroid cancer. Mol Med Rep.
5:1267–1270. 2012.PubMed/NCBI
|
|
24
|
Volz NB, Stintzing S, Zhang W, Yang D,
Ning Y, Wakatsuki T, El-Khoueiry RE, Li JE, Kardosh A, Loupakis F,
et al: Genes involved in pericyte-driven tumor maturation predict
treatment benefit of first-line FOLFIRI plus bevacizumab in
patients with metastatic colorectal cancer. Pharmacogenomics J.
15:69–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
MicroRNA-338 inhibits growth, invasion and metastasis of gastric
cancer by targeting NRP1 expression. PLoS One. 9:e944222014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin J, Zhang Y, Wu J, Li L, Chen N, Ni P,
Song L and Liu X: Neuropilin 1 (NRP1) is a novel tumor marker in
hepatocellular carcinoma. Clin Chim Acta. 485:158–165. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ding M, Liu L, Hu C, Liu Y, Qiao Y and
Jiang X: Expression of VEGFR2 and NRP-1 in non-small cell lung
cancer and their clinical significance. Chin J Cancer Res.
26:669–677. 2014.PubMed/NCBI
|
|
28
|
Wey JS, Gray MJ, Fan F, Belcheva A,
McCarty MF, Stoeltzing O, Somcio R, Liu W, Evans DB, Klagsbrun M,
et al: Overexpression of neuropilin-1 promotes constitutive MAPK
signalling and chemoresistance in pancreatic cancer cells. Br J
Cancer. 93:233–241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yue B, Ma JF, Yao G, Yang MD, Cheng H and
Liu GY: Knockdown of neuropilin-1 suppresses invasion, angiogenesis
and increases the chemosensitivity to doxorubicin in osteosarcoma
cells-an in vitro study. Eur Rev Med Pharmacol Sci. 18:1735–1741.
2014.PubMed/NCBI
|
|
30
|
Hansen TF, Sørensen FB, Spindler KL, Olsen
DA, Andersen RF, Lindebjerg J, Brandslund I and Jakobsen A:
Microvessel density and the association with single nucleotide
polymorphisms of the vascular endothelial growth factor receptor 2
in patients with colorectal cancer. Virchows Arch. 456:251–260.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Yang J, Chen Y, Mao Q, Li S,
Xiong W, Lin Y, Chen J and Ge J: Genetic variants of VEGF (rs201963
and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) are
associated with glioma risk in a Han Chinese population: A
case-control study. Mol Neurobiol. 53:2610–2618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Andrae J, Gallini R and Betsholtz C: Role
of platelet-derived growth factors in physiology and medicine.
Genes Dev. 22:1276–1312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heldin CH and Westermark B: Mechanism of
action and in vivo role of platelet-derived growth factor.
Physiol Rev. 79:1283–1316. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pietras K, Sjöblom T, Rubin K, Heldin CH
and Ostman A: PDGF receptors as cancer drug targets. Cancer Cell.
3:439–443. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heinrich MC, Corless CL, Duensing A,
McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A,
Town A, et al: PDGFRA activating mutations, in gastrointestinal
stromal tumors. Science. 299:708–710. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Duan B, Hu J, Liu H, Wang Y, Li H, Liu S,
Xie J, Owzar K, Abbruzzese J, Hurwitz H, et al: Genetic variants in
the platelet-derived growth factor subunit B gene associated with
pancreatic cancer risk. Int J Cancer. 142:1322–1331. 2018.
View Article : Google Scholar : PubMed/NCBI
|
